Company has been scrambling to raise funds to pay its many lenders, suppliers and investors
A China Evergrande Group sign is shown atop the Evergrande Center in Shanghai. Picture: BLOOMBERG/QILAI SHEN
The stock closed down 10.2% at HK$2.28 , after earlier plummeting 19% to its weakest level since May 2010. Lin said Evergrande's share price could fall to below HK$1 if the company is forced to sell most of its assets in a restructuring. Policymakers are telling Evergrande's major lenders to extend interest payments or rollover loans, and market watchers are largely of the view that a direct bailout from the government is unlikely.
In any default scenario, Evergrande will need to restructure the bonds, but analysts expect a low recovery ratio for investors. Trading of the company's bonds underscored just how dramatically investor expectations of its prospects have deteriorated this year.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
LETTER: China sets the example with nuclearWind turbines and solar panels won’t supply the base load required
Read more »
Tech crackdown not aimed at stifling private sector, China saysSteps intended to boost regulations and improve data privacy as well as national security, Wall Street executives told
Read more »
Hong Kong slides to almost 11-month low as Asian stocks sag over tapering fearsFederal Reserve meeting headlines those of a dozen central banks, including SA
Read more »
Hong Kong leads Asian sell-off as Evergrande fears spreadAsian markets fell Monday on fears about contagion from a possible collapse of teetering property giant China Evergrande, while sentiment was also dragged by the Federal Reserve's plans to taper monetary policy, surging Delta infections and signs of a weakness in the global recovery.
Read more »
Pfizer-BioNTech data shows Covid-19 vaccine safe and protective in childrenPfizer Inc and BioNTech SE said on Monday their Covid-19 vaccine induced a robust immune response in five to 11-year-olds.
Read more »